Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Gout - Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.
The prevalence of gout is on the rise, keeping pace with population growth in the 7 Major Markets (7MM) at an Annual Growth Rate (AGR) of 1.18%
Currently, the treatment options for gout in these markets primarily consist of NSAIDs, corticosteroids, and urate-lowering therapies (ULTs), with some of them having challenging safety profiles, notably allopurinol. Despite the available treatments, there are several unmet needs in this space, including the need for greater awareness of gout among both physicians and patients, as well as the necessity for improved therapies for severe gout patients.
Late-stage research and development in the gout pipeline are predominantly focused on the development of ULTs for the treatment of chronic gout. The forecast anticipates significant growth in the gout therapeutics market throughout the forecast period, driven by the steady increase in the gout patient population and the introduction of novel therapies.
This forecast covers the United States, the 5 European Union countries (France, Germany, Italy, Spain, and the UK, treated as a single entity), and Japan, spanning from 2022 to 2032.
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the gout therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the gout therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Key Topics Covered:
1. Preface
1.1. Contents
1.2. Abbreviations
1.3. Related Reports
2. Executive Summary
3. Disease Overview
3.1. Overview of Gout
3.2. Gout SWOT Analysis
3.3. Classification of Gout
4. Epidemiology
4.1. Diagnosed Prevalent Cases of Gout
4.2. Age-Specific Trends in Diagnosed Prevalent Cases of Gout
4.3. Sex-Specific Diagnosed Prevalent Cases of Gout
4.4. Sources and Methodology for Gout Prevalence
4.5. Sources and Methodology for Gout
5. Current Treatment Options
5.1. Treatment Paradigm
5.2. Marketed Products
5.3. Product Profile: NSAIDs
5.4. Product Profile: Corticosteroids
5.5. Product Profile: Krystexxa (Pegloticase)
5.6. Product Profile: Febuxostat
5.7. Product Profile: Urine Reabsorption Agents
5.8. Product Profile: Colcrys (colchicine)
5.9. Product Profile: Ilaris (canakinumab)
6. Unmet Needs and Opportunities
6.1. Unmet Needs in Gout
6.2. Physician and Patient Awareness of Gout
6.3. Noncompliance to Gout Therapies
6.4. Earlier and More Accurate Diagnosis of Gout
6.5. Efficacious and Safe Treatment of Difficult-to-Treat Gout
7. Pipeline Assessment
7.1. Gout Pipeline Overview
7.2. Leading Pipeline Agents
7.3. Product Profile: Dapansutrile
7.4. Product Profile: Urece (dotinurad) - pediatric use
7.5. Product Profile: Pegadricase
7.6. Product Profile: Tigulixostat
7.7. Product Profile: ABP-671
7.8. Product Profile: SAP-001
7.9. Product Profile: Sodium Bicarbonate
8. R&D Strategies
8.1. Gout - Clinical Trials (Phase II/III) Overview
8.2. Trends in Clinical Trial Design in Gout
8.3. Trends in Deal-Making in Gout
9. Market Outlook
9.1. Gout Sales Forecast
9.2. Gout Market Forecast
9.3. Market Drivers and Barriers
10. Appendix
A selection of companies mentioned in this report includes
- Horizon Therapeutics USA Inc
- Teijin Pharma Ltd
- Fuji Yakuhin Co Ltd
- Lipomed AG
- Novartis AG
For more information about this report visit https://www.researchandmarkets.com/r/yb3im4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
